KEY CHARACTERISTICS • Faster processing speeds (up to 1,000 m/min) at low wall thickness (100 µm) • Increased chemical resistance • Lower gel migration • ECCOH 6153 UV - optimized for Teroson • ECCOH 6154 UV - optimized for Unigel • High color rendition and compatibility with Avient masterbatch • High UV resistance • Very low shrinkage MARKET & APPLICATIONS Optical Fiber Cables including: • Stranded loose tubes – gel-filled/dry • Micro-modules • Tight buffer applications – gel-filled/dry STANDARD COMPLIANCE • IEC 60794 • NF XP C93-850-1-1:2020 • EN 50289-4-17:2016 • ISO 4892:2016 • ST/CNET/5843 (1998) PRODUCT BULLETIN GEL MIGRATION PERFORMANCE ECCOH LSFOH 6153/6154 UV grades offer greater gel migration performance compared to alternative ECCOH grades.

Example applications include handles, grips, bumpers, keypads, and housings on cellular phones, pagers, PDAs, PCs, laptops, printers, headsets, video, and hand-held computers.

Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 25 Capex / Revenue 2021E (%) AVIENT IS ASSET LIGHT Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 2 3 3 6 2 3 4 4 5 5 5 6 6 6 7 9 25 A vi en t A vi en t (E xc l. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 83% Median: 76% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $510M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of February 5, 2021 85 87 86 86 81 81 59 92 88 81 79 79 79 76 76 75 73 67 67 64 60 7 A vi en t P P G K W R R P M F U L A V Y G C P IF F F M C U N V R H X L E M N B N R E C L C E A S H F O E G R A H U N K R A S C L A L B Source: Peer data per Bloomberg market data as of February 5, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation implies an EBITDA multiple that is significantly below specialty formulator peers and our historic valuations, when the company had considerable exposure to more cyclical and challenging end markets. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 27 Avient reflects 2021 estimated EBITDA of $510M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 9.5 21.1 13.2 13.2 12.0 12.0 9.7 25.2 23.1 14.7 13.5 12.9 11.0 11.0 11.0 10.2 9.6 9.3 9.3 9.1 8.6 8.3 A vi en t K W R A V Y R P M G C P P P G F U L A L B E C L H X L IF F F M C G R A B N R F O E A S H C E S C L U N V R E M N H U N K R A Median: 11.0xMedian: 12.6x SUMMARY: WHY INVEST IN AVIENT?

Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 26 Capex / Revenue 2021E (%) AVIENT IS ASSET LIGHT Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 2 3 3 4 3 3 3 4 4 5 5 5 6 7 7 8 24 A vi en t A vi en t (E xc l. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 84% Median: 77% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $560M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of April 27, 2021 87 89 87 86 82 81 76 88 87 84 82 81 78 77 77 77 76 73 70 69 50 19 A vi en t K W R P P G R P M A V Y F U L G C P F M C IF F H X L U N V R E C L A S H C E B N R F O E E M N G R A H U N K R A S C L A L B Source: Peer data per Bloomberg market data as of April 27, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the majority of our chemical peers. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 28 Avient reflects 2021 estimated EBITDA of $560M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 10.2 17.7 16.0 14.9 14.6 11.6 11.1 26.7 24.0 22.8 14.3 12.7 11.5 11.2 11.1 11.0 10.3 10.1 9.5 9.4 8.3 7.0 A vi en t K W R A V Y R P M P P G G C P F U L A L B H X L E C L IF F F M C B N R A S H G R A F O E S C L E M N U N V R C E K R A H U N Median: 11.1xMedian: 14.8x SUMMARY: WHY INVEST IN AVIENT?

OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 5.4 8.5 10.1 10.0 15.7 15.0 14.2 12.7 10.2 25.0 19.7 17.7 13.2 12.3 10.0 9.9 8.9 8.5 8.3 6.6 A vi en t (2 01 1) A vi en t (2 01 6) A vi en t (2 02 1) A vi en t (T o da y) R P M K W R P P G A V Y F U L A L B E C L H X L A S H F M C B N R E M N U N V R C E S C L H U N Historic Multiple SUMMARY: WHY INVEST IN AVIENT?

https://www.grandviewresearch.com/industry-analysis/recycled-polyethylene-terephthalate-pet-market https://www.spglobal.com/platts/en/market-insights/blogs/petrochemicals/022621-us-plastic-recycling-pet-bottles-packaging-waste-investment https://ec.europa.eu/environment/topics/plastics/single-use-plastics_en Supply & Demand Currently, demand for rPET is outpacing the supply. https://www.spglobal.com/platts/en/market-insights/blogs/petrochemicals/022621-us-plastic-recycling-pet-bottles-packaging-waste-investment What’s Up Next for rPET?

Bu yasalar, rekabetçi pazarların tüketicilere en iyi ürün ve hizmetleri en düşük fiyatlarla sağlayacağı inancını yansıtırlar. İhale Rotasyonu”, tüm işbirlikçilerin teklif sunduğu ancak sırayla en düşük teklifi verdikleri durumdur. En ciddi suçlar, rakip şirketler arasında rekabeti kısıtlayan yatay anlaşmalar yapılmasıdır.

They are available for processes including extrusion, injection molding, blow molding, rotational molding and thermoforming. 1. https://www2.deloitte.com/us/en/pages/technology-media-and- telecommunications/articles/global-mobile-consumer-survey-us-edition.html 2. https://cals.arizona.edu/news/why-your-cellphone-has-more-germs-toilet www.avient.com Copyright © 2020, Avient Corporation.

DEFENSE • Battlefield simulation • Flight & vehicle simulation • Medic training • Virtual bootcamp CO NSUMER E DU CATION • Video games • Live events • Video entertainment • Theatre • Virtual theme parks • Virtual museums & galleries • Virtual immersion • Global connectivity HEALTHCARE • Surgical simulation • Phobia treatment • Robotic surgery • Skills training • Diagnostics RETAIL & FASHION• Virtual stores • 3D human forms for design • 3D fashion portfolios REAL ESTATE EN GINEERING • 3D modeling tools • Design tools • Prototyping • Construction • Architectural design • Virtual tours 1.844.4AVIENT www.avient.com Copyright © 2020, Avient Corporation.